A detailed history of New England Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, New England Asset Management Inc holds 175,813 shares of PFE stock, worth $4.83 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
175,813
Previous 175,298 0.29%
Holding current value
$4.83 Million
Previous $4.9 Million 3.75%
% of portfolio
0.84%
Previous 0.86%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$27.7 - $31.39 $14,265 - $16,165
515 Added 0.29%
175,813 $5.09 Million
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $70,728 - $82,880
-2,800 Reduced 1.57%
175,298 $4.9 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $207,120 - $237,840
8,000 Added 4.7%
178,098 $4.94 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $71,674 - $93,097
2,743 Added 1.64%
170,098 $4.9 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $256,880 - $300,267
-8,005 Reduced 4.56%
167,355 $5.55 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $306,060 - $398,445
-7,770 Reduced 4.24%
175,360 $7.15 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $199,481 - $260,401
-4,778 Reduced 2.54%
183,130 $9.39 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $395,065 - $482,275
9,028 Added 5.05%
187,908 $8.22 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $51,183 - $60,687
1,100 Added 0.62%
178,880 $9.38 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $123,525 - $153,063
2,700 Added 1.54%
177,780 $9.2 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $254,118 - $376,687
6,150 Added 3.64%
175,080 $10.3 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $414,205 - $532,082
10,553 Added 6.66%
168,930 $7.27 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $71,640 - $81,156
1,995 Added 1.28%
158,377 $6.2 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $80,376 - $90,648
2,400 Added 1.56%
156,382 $5.67 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $93,716 - $119,168
2,800 Added 1.85%
153,982 $5.67 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $130,175 - $152,725
-4,100 Reduced 2.64%
151,182 $5.55 Million
Q2 2020

Aug 17, 2020

SELL
$30.12 - $36.54 $310,236 - $376,362
-10,300 Reduced 6.22%
155,282 $5.08 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $236,512 - $337,925
8,750 Added 5.58%
165,582 $5.41 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $69,132 - $78,456
-2,100 Reduced 1.32%
156,832 $6.15 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $48,073 - $53,976
-1,300 Reduced 0.81%
158,932 $6.89 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $237,000 - $260,384
6,320 Added 4.11%
160,232 $6.81 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $178,885 - $203,949
4,650 Added 3.12%
153,912 $6.72 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $13,615 - $16,514
395 Added 0.27%
149,262 $6.58 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $61,342 - $65,397
1,860 Added 1.27%
148,867 $5.4 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $38,292 - $44,424
1,200 Added 0.82%
147,007 $5.22 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $83,150 - $88,225
-2,500 Reduced 1.69%
145,807 $5.28 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $4.6 Million - $5.06 Million
148,307
148,307 $5.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track New England Asset Management Inc Portfolio

Follow New England Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on New England Asset Management Inc with notifications on news.